Search results for "Eye"

showing 10 items of 2511 documents

Biografia - Oscar Niemeyer

2018

La scheda biografica ripercorre i momenti più significativi dell'attività professionale dell'architetto brasiliano Oscar Niemeyer che durante i suoi settant'anni di carriera si occupò di opere a carattere espositivo e museale, di edifici multifunzionali, di architettura sacra, di interventi paesaggistici e urbani su vasta scala e della realizzazione di case uni-familiari lavorando in Algeria, in Brasile, in Francia e in Italia.

Disegno progetto Oscar Niemeyer modellazione digitaleSettore ICAR/17 - Disegno
researchProduct

Objective assessment of the effect of pupil size upon the power distribution of multifocal contact lenses

2017

AIM: To analytically assess the effect of pupil size upon the refractive power distributions of different designs of multifocal contact lenses. METHODS: Two multifocal contact lenses of center-near design and one multifocal contact lens of center-distance design were used in this study. Their power profiles were measured using the NIMO TR1504 device (LAMBDA-X, Belgium). Based on their power profiles, the power distribution was assessed as a function of pupil size. For the high addition lenses, the resulting refractive power as a function of viewing distance (far, intermediate, and near) and pupil size was also analyzed. RESULTS: The power distribution of the lenses was affected by pupil siz…

Distribution (number theory)genetic structuresLentes de contactoOptical powerAstrophysics::Cosmology and Extragalactic Astrophysicslaw.inventionObjective assessment03 medical and health sciences0302 clinical medicineOpticsClinical ResearchlawMedicineComputer visionbusiness.industryPupil sizeeye diseasesPower (physics)Lens (optics)Contact lensOphthalmologyPupil magnification030221 ophthalmology & optometryOftalmologíaArtificial intelligencesense organsbusiness030217 neurology & neurosurgery
researchProduct

Expression of the transcription factor Pax6 in the adult rat dentate gyrus

2005

The transcription factor Pax 6 is expressed in precursor cells during embryonic CNS development, and it plays an important role in the regulation of cell proliferation and neuronal fate determination. Pax 6-expressing cells are also present in the adult hippocampal dentate gyrus and subventricular zone/rostral migratory stream, regions in which neuronal precursors exist during adult life. In the adult dentate gyrus, precursor cells are located in the innermost portion of the granule cell layer, and Pax 6-expressing nuclei are most abundant in this region. To examine the putative role of Pax 6 in adult hippocampal neurogenesis, we have studied the proliferative activity, distribution, and ph…

Doublecortin Domain ProteinsMalePAX6 Transcription FactorAntimetabolitesGreen Fluorescent ProteinsSubventricular zoneNerve Tissue ProteinsHippocampal formationBiologyNestinRats Sprague-DawleyCellular and Molecular NeuroscienceIntermediate Filament ProteinsGlial Fibrillary Acidic ProteinBasic Helix-Loop-Helix Transcription FactorsmedicineAnimalsPaired Box Transcription FactorsEye ProteinsCell ProliferationHomeodomain ProteinsNeuronsStem CellsDentate gyrusNeuropeptidesNeurogenesisGranule cellImmunohistochemistryRatsRepressor ProteinsNeuroepithelial cellNeuropoiesismedicine.anatomical_structureBromodeoxyuridinenervous systemDentate GyrusPAX6Plant LectinsMicrotubule-Associated ProteinsNeuroscienceJournal of Neuroscience Research
researchProduct

Q fever: a new ocular manifestation

2011

P Udaondo1,3, S Garcia-Delpech1,2, D Salom1,2, M Garcia-Pous1, M Diaz-Llopis1,21Department of Ophthalmology, Nuevo Hospital Universitario y Politecnico La Fe, Valencia, Spain; 2Faculty of Medicine, Universitat de València, Valencia, Spain; 3Universidad Cardenal Herrera CEU, Valencia, SpainAbstract: Q Fever is a zoonosis caused by Coxiella burnetii. Ocular manifestations are rare in this infection. We describe the case of a man complaining of an intense retro-orbital headache, fever, arthralgia, and bilateral loss of vision, who showed an anterior uveitis accompanied by exudative bilateral inferior retinal detachment and optic disk edema. At the beginning, a Vogt–Koyanag…

Doxycyclineexudative retinal detachmentmedicine.medical_specialtybiologyVkh syndromebusiness.industryPanuveitispanuveitisRetinal detachmentQ feverCase ReportExudative retinal detachmentRE1-994Coxiella burnetiibiology.organism_classificationmedicine.diseaseVogt-Koyanagi-Harada syndromeComplete resolutioneye diseasesOphthalmologyOphthalmologymedicinebusinessQ fevermedicine.drugClinical Ophthalmology
researchProduct

Anotaciones sobre el Misterio de Elche

1996

Drama litúrgicoObras de referenciaApócrifosDevoción marianaUNESCO::HISTORIA::Historia por especialidades::Historia del arteCultoLeyendasFuentes literariasEscenografía:HISTORIA::Historia por especialidades::Historia del arte [UNESCO]
researchProduct

Intraoperative dexamethasone intravitreal implant in diabetic macular edema patients undergoing phacoemulsification: The CataDex study

2021

Purpose To assess the impact of preoperative intravitreal dexamethasone implant (DexI) on functional and anatomic outcomes in patients with diabetic macular edema (DME) who underwent phacoemulsification cataract surgery. Methods Prospective and non-comparative study conducted on consecutive DME patients undergoing cataract surgery. DexI was administered 15 days before surgery and in a pro re nata regime after surgery. Main outcome measures were mean change in central retinal thickness (CRT), central subfield thickness (CST), total macular volume (TMV), and central subfield volume (CSV) from baseline to month-12. Secondary outcome was mean change in best corrected visual acuity (BCVA). Resul…

Drug ImplantsDiabetic Retinopathygenetic structuresSettore MED/30 - Malattie Apparato Visivoreal worldGeneral Medicineeye diseasesDexamethasoneMacular EdemaOphthalmologycataractIntravitreal InjectionsphacoemulsificationDiabetes MellitusHumansProspective StudiesDexamethasone implantdiabetic macular edemaGlucocorticoidsTomography Optical Coherence
researchProduct

Stability of tacrolimus ophthalmic solution

2017

Purpose The stability of 0.3-mg/mL tacrolimus ophthalmic solution at different storage temperatures was studied. Methods A sterile ophthalmic solution of 0.3 mg/mL tacrolimus was prepared in triplicate under aseptic conditions by diluting tacrolimus in eye drops. Three aliquots of this solution were transferred into polypropylene bottles and stored at 25, 2–8, or −15 to −25 °C. Samples were collected immediately after preparation and at selected time points and assayed in triplicate using high-performance liquid chromatography (HPLC). Samples were also visually examined for macroscopic changes. The 0.3-mg/mL tacrolimus solution was also exposed to acidic treatment and heat to force its degr…

Drug Storagemedicine.medical_treatmentAdministration Ophthalmicchemical and pharmacologic phenomena030226 pharmacology & pharmacyHigh-performance liquid chromatographyTacrolimus03 medical and health sciences0302 clinical medicineDrug StabilitymedicineHumansChromatography High Pressure LiquidPharmacologyChromatographyChemistryHealth PolicyTemperatureEye dropTacrolimusPharmaceutical Solutionssurgical procedures operativeOphthalmic solutionsAnesthesia030221 ophthalmology & optometryAseptic processingOphthalmic SolutionsImmunosuppressive AgentsAmerican Journal of Health-System Pharmacy
researchProduct

Rapid in vitro test to predict ocular tissue permeability based on biopartitioning micellar chromatography.

2003

The drug permeability prediction across the ocular tissues is important in the development of new drugs and drug delivery strategies. Physicochemical characteristics of drugs, mainly acid-base character, hydrophobicity and the molecular size determine both their transport across the eye tissue barriers and their retention in biopartitioning micellar chromatography (BMC). An in vitro model able to describe and predict the whole cornea drug permeability is proposed. The model uses the retention of drugs in BMC and molecular weight (MW) as predictive variables. The relationships between drug retention data in BMC and their bibliographic permeability values in stroma, epithelium-plus-stroma and…

DrugOctanolsIn vitro testChemical Phenomenamedia_common.quotation_subjectPharmaceutical ScienceEyeModels BiologicalPermeabilityCorneaOcular tissueDrug permeabilityPredictive Value of TestsCorneamedicinemedia_commonChromatography Micellar Electrokinetic CapillaryChromatographyDrug discoveryChemistryChemistry PhysicalPermeability (earth sciences)medicine.anatomical_structureData Interpretation StatisticalDrug deliveryIndicators and ReagentsSpectrophotometry UltravioletEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Microfibrillar polymeric ocular inserts for triamcinolone acetonide delivery.

2019

Abstract Despite eye drops generally represent the most convenient, simple and patient-friendly formulations to treat ocular diseases, they suffer from poor retention on the ocular surface and low drug bioavailability leading to the necessity of prolonged and continuous treatment over time. Therefore, ocular insert could represent an innovative way to benefit from ocular topical administration while minimizing all the relevant limitation related to this route of administration. Polymeric non-erodible mucoadhesive ocular inserts should be comfortable and should rapidly adhere on the ocular surface, remain in situ for prolonged period, assure a reproducible and controlled drug release as well…

DrugTriamcinolone acetonidegenetic structuresPolymersmedia_common.quotation_subjectPoly(butylene succinate) (PBS)Pharmaceutical ScienceAdministration Ophthalmic02 engineering and technologyAbsorption (skin)Eye030226 pharmacology & pharmacyTriamcinolone Acetonide03 medical and health sciencesRoute of administration0302 clinical medicinemedicineMucoadhesionAnimalsHumansSettore BIO/15 - Biologia FarmaceuticaButylene GlycolsGlucocorticoidsmedia_commonDrug ImplantsElectrospinningPlasma-assisted surface functionalizationChemistry021001 nanoscience & nanotechnologyeye diseasesBioavailabilityPolyesterDrug LiberationSurface modificationCattleOcular insert0210 nano-technologymedicine.drugBiomedical engineeringInternational journal of pharmaceutics
researchProduct

Teprotumumab for the treatment of active thyroid eye disease

2020

Abstract Background Thyroid eye disease is a debilitating, disfiguring, and potentially blinding periocular condition for which no Food and Drug Administration–approved medical therapy is available...

Drugmedicine.medical_specialtyBlindingmedia_common.quotation_subjectEye diseaseMedizin030204 cardiovascular system & hematologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawOphthalmologymedicine030212 general & internal medicinemedia_commonTeprotumumabbusiness.industryThyroidGeneral Medicinemedicine.diseaseDermatologyeye diseasesClinical trialmedicine.anatomical_structuresense organsbusinessMedical therapymedicine.drug
researchProduct